 outcom day age low birth weight infant singl dose synthet surfact ident double-blind trial administr singl ml/kg dose synthet surfact exosurf neonat deliveri infant birth weight gm rate surviv bronchopulmonari dysplasia trial plan sampl size avail exosurf provis treatment investig new drug program combin result trial studi infant birth weight gender random assign treatment regimen ninety-two infant exosurf air placebo studi group similar varieti demograph featur mother pregnanc circumst birth infant exosurf-tr infant oxygen respiratori support first day life comparison air-treat infant infant exosurf group pulmonari interstiti emphysema exosurf group signific reduct combin outcom neonat death surviv bronchopulmonari dysplasia signific increas rate surviv diseas differ treatment group incid varieti complic prematur apnea patent ductu arteriosu intraventricular hemorrhag enterocol improv respiratori physiolog singl prophylact dose exosurf result increas likelihood neonat surviv bronchopulmonari dysplasia